The meeting focused on the evidence base for the revision of the updated “Guide to public health measures to reduce the impact of influenza pandemics in Europe”, with a specific emphasis on non-pharmaceutical countermeasures for pandemic flu.

​Experts from ECDC met representatives from influenza vaccine manufacturers to discuss prevention of influenza in Europe.